Although the receiver operating characteristic (ROC) analysis supports the potential of LRFN4 as a prognostic biomarker, its predictive ability is confounded by factors such as tumor heterogeneity, immune infiltration, and genetic alterations. The gene discussed is LRFN4; the disease is neoplasm.